Skip to content
Search

Latest Stories

PSNC launches Pharmacy Pressures Survey 2023

The Pharmaceutical Services Negotiating Committee (PSNC) has launched Pharmacy Pressures Survey 2023 to make case against the ‘unprecedented financial and operational challenges’ faced by the community pharmacies in England.

The Committee has urged those working in or owns a community pharmacy to ‘take part’ in the survey.


“The survey results will be critical to help us to show Government and the NHS how difficult things now are for pharmacies, and to persuade them to take action. We will be using the results in our negotiations, in our conversations with MPs, Ministers and in national media work as part of the joint #saveourpharmacies campaign,” said PSNC.

The Pharmacy Pressures Survey is once again comprised of two surveys to give insight into both financial and operational pressures.

Together with the other national pharmacy organisations PSNC are working both to show policy makers the severity of the problems and to lobby for Government and NHS action to ease the pressures.

The surveys will be open for completion until COP Monday 20th February.

There are two separate surveys for:

  • Pharmacy business owners/head office representatives

    This survey covers the pressures being experienced by businesses, looking at the overall running of the pharmacy business including financial and staffing pressures. Please note that only one representative from each pharmacy business should complete this survey – please check this is the case before doing so.

  • Pharmacy teams

    This survey covers the day-to-day pressures experienced by pharmacy teams including supply chain issues, patient interactions/experience and staff morale.

“Independent contractors or pharmacy owners who also work day-to-day in a pharmacy are very welcome to complete both surveys if they would like to, or they could complete the owners survey and encourage team members to complete the team survey.

PSNC Chief Executive Janet Morrison said: “Last year our Pressures Survey received a huge number of responses for which we were so grateful. The results have been invaluable: we still use them regularly to highlight the problems facing community pharmacies, including using them as part of our negotiations, sharing them with Ministers and MPs, and citing them in Parliamentary briefings and national media work.

In recent months we have invested significantly in our influencing work to get the message across to Government and NHS England that the community pharmacy network is facing a fearsome range of pressures and challenges. The sector is on its knees and the consequences of the current funding situation, and the damage of increasing business costs, means a serious risk of collapse.

To help us to keep making the case and to push for short and long-term funding increases, we are asking contractors and pharmacy teams to help us once again. A big response to these surveys will give us an accurate and persuasive snapshot of the scale of the problems the sector is facing which we can use in all our influencing work and negotiations.

Data always helps us to make our case, and the 2023 survey will provide us with further evidence to support our arguments – both in our ongoing discussions, and through public and Parliamentary forums. This year we have also partnered with the other national pharmacy organisations on a #SaveOurPharmacies campaign and the results of the Pressures Survey will be a key focus for that, with media and Parliamentary coverage already being planned.

We very much hope that as many people in the sector as possible will be able to take part, and I’d like to thank everyone in advance who will take the time to fill in these surveys: we really value your input.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less